Virgile Richard

Virgile Richard Email and Phone Number

Pathology consultant at SCIEMPATH BIO @ SCIEMPATH BIO
Virgile Richard's Location
Belgium, Belgium
Virgile Richard's Contact Details

Virgile Richard personal email

About Virgile Richard

Experimental pathologist with experience for building investigative histopathology laboratories dedicated to translational research, drug discovery and pre-clinical safety, experience in managing highly diverse and small to medium size teams project management skills including an ability to set objectives and manage multiple projects. Extensive experience of designing, validating and implementing investigative and translational pathology studies in a variety of therapeutic areas (immuno-oncology, obesity and metabolic disorders, allergy and respiratory, endocrinology, urinary, and infectious diseases TA)Extensive knowledge in molecular techniques applied to histology. Extensive experience in the development and operation of imaging facilities and methods applied to pathology using digital slide scanner and computer-assisted image analysis (Image-Pro plus, Definiens, and Visiopharm). Excellent understanding of GLP regulations and experience in GLP implementation in a histopathology laboratory.Good experience in pre-clinical safety and ability to develop and implement safety strategy to enable FIH studies. Additional key scientific knowledge includes comparative immunology, oncology, cell biology and signaling, virology, and endocrinology.Specialties: Pathology, in vivo models, automated pathology imaging, translational biology, molecular biology, laboratory management, drug discovery and development project management.

Virgile Richard's Current Company Details
SCIEMPATH BIO

Sciempath Bio

View
Pathology consultant at SCIEMPATH BIO
Virgile Richard Work Experience Details
  • Sciempath Bio
    Pathology Consultant
    Sciempath Bio May 2014 - Present
    Brabant, Walloon Region, Belgium
    Molecular pathology organization oriented toward professional services in pre-clinical pathology applied to translational animal models, non-regulatory and regulatory studies used in drug discovery and early development projects Perform standard or molecular histopathology interpretation in predictive and mechanistic drug safety or efficacy studies. Provide pathology expertise in studies for novel target identification and biomarkers (IHC/IF, laser capture microscopy and downstream molecular techniques) in pre-clinical and clinical samples Provide expertise and services in the design, development and full characterization of pre-clinical mechanistic safety studies, including transgenic models. Perform full section histomorphometric analysis using Image-Pro and/or Visiopharm softwares. Provide professional consultancy for drug discovery and development programs in regards to preclinical safety data in order to support regulatory submissions and out-licensing opportunities.
  • Sciempath Labo
    Ceo
    Sciempath Labo Jan 2018 - Present
    Tours, Centre-Val De Loire, France
    Managerial and scientific director of a CRO specialized in molecular pathology
  • Ucb Pharma
    Molecular Pathologist - Investigative Toxicology
    Ucb Pharma Jan 2011 - Dec 2013
    Braine-L’Alleud, Walloon Region, Belgium
    Design molecular histopathology procedures for mechanistic drug safety studies Design and participate to full characterization of pre-clinical mechanistic safety studiesInterpret studies for novel candidate safety biomarker identification and/or target distribution using molecular pathology approaches.Act as peer review pathologist to support UCB regulatory safety studies. Core team member of the Disease Area Team in Alzheimer/Cognition defining therapeutic research strategies to identify new targets through molecular pathway analysis and collaborative external research projects,
  • Novartis
    Head Of Investigative Molecular Histopathology
    Novartis Jul 2008 - Oct 2010
    Cambridge, Massachusetts, United States
    Management of a molecular and research pathology laboratory applied to translational animal models used in drug discovery and early development projects to investigate the mechanisms of toxicity observed during pre-clinical and clinical drug development Pre-Clinical Safety representative for Drug Discovery programs ranging from HTS to pre-IND stageInvestigative Toxicology representative for late development programs
  • Pfizer
    Investigative Pathology Laboratory Leader
    Pfizer Jan 2004 - May 2008
    Managerial and scientific responsibilities (50%)Manage an Investigative Pathology lab (R&D)Member of the drug safety department LTSupervise pathology procedures in efficacy and safety studiesDevelopment/characterization of animal modelsDesign experiments for drug target expression Supervise studies for target ID using translational modelsValidate efficacy/safety translational biomarkers in animal tissues Evaluate histopathological changes in animal tissuesSupervise studentsDrug Discovery/Development Responsibilities (40%)Team member for programs ranging from HTS to pre-FIH stage; Team member of the Translational Biology groups Global responsibilities (10%)Leader for Target Tissue Characterization initiativeLeader for High-throughput Automated Image Analysis initiative Member of the Global Immunotoxicology CouncilMember of the Global Investigative Pathology LTPfizer representative for the European inter-Pharma CEPA group
  • Universit�� Laval
    Pathologist And Head Of Histopathology And Toxicology
    Universit�� Laval Sep 1994 - Sep 1998
    Established and managed an anatomic pathology laboratory conformable to GLP regulationsPerformed/supervised necropsy, histopathology, and other post-mortem experimental procedures in efficacy and pre-clinical drug safety studies using various animal models of human cancer (GLP environment)Evaluated histopathological and bone histomorphometric changes related to administration of selective estrogen receptor modulators and other endocrine factorsDeveloped animal models of breast and prostate cancerDesigned, performed, and evaluated in vivo and in vitro experiments in the evaluation of sexual steroids effects on uterus, mammary gland, male sexual accessory glands, and bonesInteract and participate daily in the design of GLP studies

Virgile Richard Skills

Translational Medicine Clinical Development Cro Cancer Drug Development In Vitro Toxicology Pharmacology Biomarkers Biotechnology Pathology Molecular Biology R&d Drug Discovery Glp In Vivo Infectious Diseases Immunology Pharmaceutical Industry Oncology Animal Models Laboratory Histology Translational Research

Virgile Richard Education Details

Frequently Asked Questions about Virgile Richard

What company does Virgile Richard work for?

Virgile Richard works for Sciempath Bio

What is Virgile Richard's role at the current company?

Virgile Richard's current role is Pathology consultant at SCIEMPATH BIO.

What is Virgile Richard's email address?

Virgile Richard's email address is vi****@****hoo.com

What schools did Virgile Richard attend?

Virgile Richard attended The Ohio State University, Université De Montréal, Université De Montréal.

What skills is Virgile Richard known for?

Virgile Richard has skills like Translational Medicine, Clinical Development, Cro, Cancer, Drug Development, In Vitro, Toxicology, Pharmacology, Biomarkers, Biotechnology, Pathology, Molecular Biology.

Not the Virgile Richard you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.